investigated both CTLA-4 and PD-L1 expressions in immune cells and reported that CTLA-4 overexpression correlated with favorable prognostic features, including the absence of lymphovascular invasion and lower pathological tumor and nodal stages (12). The gene discussed is CD274; the disease is neoplasm.